objective To evaluate the impact of the national essential medicines scheme and zero-mark-up policy on antibiotic prescribing behaviour.
Introduction
Worldwide more than half of medicines are inappropriately prescribed and dispensed [1] . Overuse of antibiotics is a global public health problem that contributes to the rise of antimicrobial resistance [2] . Every year more than 10 million children died of bacteria-resistant infections, most in low-and middle-income countries (LMICs) [3] . China, especially its rural areas, faces similar challenges as over 70% of common colds and other acute upper respiratory tract infections (URTIs) were treated with antibiotics [4] .
One of the important drivers for medication overuse in China was financial incentives because public hospitals charge 15% or more as markups for prescribed medicines based on their procurement prices. This was introduced in early 1980s as a compensation to the substantially reduced government subsidies [5] . Medication markups later became the most import source of income for hospitals (>50%) [5, 6] . In 2009, China issued the national essential medicines scheme and zero-mark-up policy to improve rational use of medicines by disengaging prescribing from profits. There is a basic package of medicines at the national level, then provincial and lower level governments extend the list according to their needs. Medicines not on the list are not allowed or encouraged in prescriptions. All essential medicines should be procured from a province-wide centralised bidding and supply chain system. No markup is added for medications on the list prescribed at public hospitals [7] . To offset the losses in hospital revenues, local governments provided specific subsidies, but many failed; until a later comprehensive subsidy plan was developed based on hospital's overall volume of health service and performance assessments [7] . However, hospitals were never sufficiently compensated, and many faced financial difficulties [8] .
The policy was first introduced to primary care facilities in 2009, then in county hospitals in 2012 and expanded to all hospitals in 2017 [7] .
Previous studies were conducted in primary care facilities and focused on the impact on costs [7] . It was reported that hospitals under the policy experienced substantial revenue loss from outpatient and inpatient care [9, 10] . But these studies were insufficiently designed to assess its impact on rational use of medicines. Since 2011, the policy was expanded to cover county hospitals, the largest providers of health care in rural areas [7] . This study aimed to assess the impact of the policy on antibiotics prescribing for childhood UTRIs in county hospitals.
Methods

Study setting
A natural experimental study was conducted in two counties in rural Guangxi, China. Guangxi province is located in the southwestern China, bordering Vietnam and Laos. We chose Guangxi as it is one of the leastdeveloped areas where inappropriate use of antibiotics is widespread [11] . It was part of a baseline study before the trial was implemented in 2015 [12] . We chose R County as the natural intervention group because the policy has been implemented in its County Hospital since January 2012. Another site, F County Hospital, was chosen as the comparison; there the policy was not been implemented until May 2015. The two counties are rural, have a similar per capita income of USD 1300 (RMB 8000) in 2013 and share similar distances to the provincial capital (3 h by driving). However, R County has almost twice the population (810 000) as F County (440 000) in 2013 [13] . At the hospital level, doctors in both institutions have similar educational backgrounds (60% with MBBS degree) and experience (the majority, 45%, at the middle level called physician in charge), except that R hospital had twice as many physicians, and 1.5 times as many inpatient beds as F hospital. In this study, we considered the baseline period as 1 January 2011 to 30 December 2011 and the intervention period as 1 January 2014 to 30 December 2014 . No data were collected in 2012/13 to allow a window period for logistic preparation in policy implementation, and a buffer period until the R health authority provided subsidies to its County Hospital in 2013.
Participants and data collection
We chose childhood URTIs because they are common and mostly viral. Use of antibiotics does not shorten the duration or prevent complications, unless the infection is bacterial and/or symptoms are severe [14] . Thus, the antibiotic prescribing rate for outpatient childhood UTRIs provides a 'proxy' to measure the appropriateness of prescribing behaviour use in health facilities [15] . Children aged 2-14 years presenting in the county hospitals with a primary diagnosis of URTIs were included in the study. URTIs were defined according to the International Classification of Diseases, 10th Revision [16] . We excluded children younger than 2 years because of their vulnerability to secondary bacterial infections, and outpatient children whose secondary diagnosis were chronic diseases and who had complications such as pneumonia, congenital heart disease, tuberculosis, immune suppression diseases and other special conditions which require antibiotics. Due to the limited number of cases, we included inpatient records whose secondary diagnosis included lower respiratory tract infections.
We extracted all outpatient prescriptions and inpatient information with primary diagnosis as URTIs from their electronic hospital information system at baseline (January 2011 to December 2011) and intervention (January 2014 to December 2014) periods, and photocopied related laboratory test results if not shown in electronic format. Each hospitalisation was considered as one episode of being an inpatient regardless of number of consultations during the period. Data were double-checked by two independent reviewers before input. Hospital names and all patient identifiable information were anonymised for confidentiality.
Measurement
Outpatient antibiotic prescription rate (APR) for childhood URTIs was the primary outcome indicator. For inpatients, we organised clinical review to determine inappropriate APR. Three physicians (two general physicians and one paediatrician) were blinded to the source of prescriptions and assessed inpatient records (Figure 1 ). Inappropriate antibiotics use refers to using antibiotics without medical indications according to a set of criteria regarding symptoms and duration, physical examinations and laboratory tests, based on Chinese and international antibiotic use guidelines [17] [18] [19] . Partly appropriate antibiotics use refers to using antibiotics with medical indications; however, its use of dosage, duration, type or category is inappropriate. Any inconsistent results between assessors were discussed among the three until a consensus was reached.
Secondary outcome indicators were assessed out of prescriptions containing antibiotics, including (i) multi-APR, (ii) broad-spectrum APR, where amoxicillin-clavulanate, second-or third-generation cephalosporins and azithromycin used based on American Association of Pedestrians' prescribing guidelines for URTIs [20] , (iii) rate of intravenous infusion of antibiotics and (iv) the average cost per prescription with antibiotics. For inpatients, we examined the average duration applying antibiotics.
Data analysis
All data were analysed using Stata 13.1 (StataCorp LP, College Station, TX, USA). We employed difference-indifferences analysis [21] to explore the potential policy effect on antibiotics prescribing at the individual level over the two time periods (2011 vs. 2014), after adjusting potential confounding variables including patients' age, gender, whether the prescription was issued on a weekday or not and secondary diagnosis of lower respiratory tract infections for inpatient records. We applied DID analysis using equation (1):
where treat reflects the groups (the intervention hospital = 1 vs. the comparison hospital = 0), and period reflects pre or post the policy implementation (intervention period = 1 vs. baseline period = 0). X indicates the controlled variables. The parameter b 3 stands for the DID estimator. P < 0.05 indicated statistically significance. We conducted logistic regression models for binary dependent variables including whether or not containing antibiotics, multiple antibiotics, broad-spectrum antibiotics or using intravenous infusions. Linear regressions were employed for continuous dependent variables such as prescription costs and days of using antibiotics.
Qualitative data collection and analysis
We conducted semi-structured in-depth interviews in both groups in March 2015 to understand (i) the practice of antibiotic prescribing and any other control measures, (ii) how the policy was implemented at the hospital level and (iii) whether there were any other policies that may be related to antibiotic prescribing, as these were unavailable in our database. Sampling was purposive based on our understanding of the context, which included paediatricians (three in each group), hospitals pharmacy heads (one in each group), hospital directors (one in each group) and health bureau officials (one in each group).
All interviews were conducted face-to-face in a quiet location in hospitals by experienced postgraduate students. We audiorecorded and also took notes on all interviews in Chinese, and later transcribed them verbatim into NVivo 10 (QSR International). We employed the thematic framework analysis containing five stages: familiarisation with the data, agreement of coding framework, indexing (in Chinese), charting (in Chinese) and interpretation (in English) [22] . The research team developed a coding framework based on existing literature, while no extra codes emerged during the analysis. Two researchers independently used this framework and indexed the transcripts into codes. Any discrepancies were discussed and doublechecked by another researcher. Emerging themes were discussed extensively and then agreed in consensus. They were back-translated to verify the original transcripts.
Ethical approval
Ethics approval was obtained from Guangxi Institute Review Boards (GXIRB2014-0036) and the University of Leeds Research Ethics Committee (MREC15-016), which agreed that patient consent was unnecessary for record review as we obtained institutional consent in county hospitals to collect anonymous patient data.
Results
Outpatients
In the intervention group, 3767 and 4452 eligible outpatient prescriptions with childhood UTRIs were collected in 2011 and 2014, respectively; while in the comparison group, 1809 were collected in 2011 and 2333 in 2014. Prescriptions of the two groups shared similar characteristics: the majority were for boys between 2 and 5 years old, and given during weekdays, although small but significant variations occurred (Table 1) . In both years, most prescriptions in the intervention contained less than five medications, but contained six or more in the comparison group. Average prescription cost decreased from 16 to 4 USD in the intervention, but doubled from 23 to 43 USD in the comparison group (P < 0.001).
APR has reduced significantly in the intervention for children URTIs (À21%, 95% CI: À23%, À18%, Table 2 ) vs. the comparison. In 2011, 33% prescriptions with antibiotic in the intervention included penicillin V, and 43% included cephalosporin III; while these patterns shifted to 74% penicillin V and 23% cephalosporin II in 2014. In the comparison group, 49% were penicillin V and 39% cephalosporin III in 2011, while 39% were penicillin V and 60% cephalosporin III in 2014 (Table S1 ). Multi-APR was rare in the intervention (<10%), but high in the comparison group (>55%). We also observed a significant decrease in given intravenous infusion for antibiotics in the intervention vs. the comparison group (À58%, 95% CI: À64%, À52%). Average costs per prescription with antibiotics reduced 31 USD in the intervention vs. the comparison group(À31, 95% CI: À35, À28).
Inpatients
We collected 74 inpatient records with primary diagnosis of URTIs in 2011 and 51 in 2014 in the intervention, and 59 and 67 in 2011 and 2014, respectively, in the comparison group. In both groups, most inpatient cases were girls, 2-5 years old and hospitalised for 4-5 days (Table 3) . No significant change was found regarding inappropriate APR, as it decreased from 51% to 42% in the intervention group but almost no change (55%) in the comparison group (Table 4 ). The majority was prescribed cephalosporin and penicillin V in both groups.
Qualitative findings
All 12 participants were successfully interviewed. The policy has changed pharmaceutical practice in the intervention hospital that over 60% of medicines were from the Essential Medicines List, which affected antibiotics availability for outpatients. 'We were only allowed 35 kinds of antibiotics. We need to eliminate an existing one, such as ciprofloxacin, to introduce a new antibiotic.
We have very limited choices', commented a paediatrician. Doctors' income in the intervention hospital was not associated with prescribing, but with patient volume.
The comparison hospital did not implement the policy, so its revenue and doctors' income were linked with drug use. We identified a new policy; that is China's antimicrobial stewardship (AMS) policy was announced in 2011, which was introduced to the intervention hospital in 2013 but not in the comparison hospital. The AMS policy requested (i) actions from the directors of the health bureau and hospitals for antimicrobial control, (ii) specific training to doctors and (iii) establishing administrative targets [23] . The intervention hospital has provided refresher training workshops regarding antibiotic prescribing based on the national antibiotic guideline [18] . Doctors commented that the training was useful, but not the guideline because it was too complicated and contained far more choices of antibiotics than what were available in their hospitals. Senior doctors interpreted how to use the guideline. The comparison hospital was informed of the AMS policy, but did not implement it. 'Our hospital's revenue was linked with medicines, so it would be counter-intuitive to limit prescribing antibiotics' as commented by a health official. Neither did it offer any training sessions for antibiotic use.
The intervention hospital conducted peer reviews and introduced penalties for overprescribing, which have played an important role in regulating antibiotic prescribing. In the intervention hospital, the county government has established an AMS Leadership Committee headed by the health bureau director and an AMS Working Group at the hospital level including heads from the hospital infection department and clinical departments. At the end of each month, the group reviewed individual doctor's diagnosis and antibiotic prescribing performance. 'We [the AMS Working Group] randomly pulled out prescriptions and reviewed them in each clinical department. We selected some prescriptions that have the potential for overuse of antibiotics, and discussed within the Group and the prescribing doctor. We identified inappropriate prescribing. Doctors who are identified over four times have their names listed in the hospital, and get their prescribing rights downgraded, i.e., less choices for antibiotics. In addition, this doctor has to take a mandatory training for a month. Up to now, several doctors have gone through it', the hospital director reported. 'The administrative penalty is more effective than financial ones because it limits how a doctor can practice', one paediatrician said. In the control group, no supervision exercise or penalties on antibiotic overprescribing were reported. The health official said, 'the health bureau intended to limit antibiotic use to 20% of all outpatient prescriptions, but we did not know how to do it. We may catch everyone if we punish high prescribers'. No other related policies were observed, such as favourable reimbursement policy of the rural health insurance scheme for non-use of antibiotics in both groups.
Discussion
Between 2011 and 2014, we observed a significant reduction in APR, use of intravenous infusions and cost per prescription among outpatient childhood URTIs in the intervention hospital, where both the national essential medicines scheme and zero-mark-up policy and the AMS policy were implemented, compared with the comparison hospital where neither was introduced. However, we did not identify any change regarding inappropriate APR for inpatients between the two hospitals. The natural experimental study design prevented us from demonstrating any causal inference between the policies and changes. We only had one intervention and one comparison hospital in this study. Although other factors at the county level (e.g. economic development) and the hospital level (e.g. doctor's education) were similar, the influence of confounding factors may not be fully balanced, or there may be other undocumented context factors influencing the results. The comparison was further complicated because the intervention hospital had much lower APR and prescription costs at baseline compared with the control. We employed difference-indifferences analyses to control baseline data and any potential confounding factors. Second, the study was conducted in two county hospitals in rural Guangxi, and its results should not be overextrapolated to other parts of China because areas differ considerably as to their implementation of national policies [21] . Third, the study was conducted in county hospitals, and the results may not apply to general practitioners in township and village clinics. However, clinicians at the lower levels receive vocational training from county hospitals, and their prescribing behaviour is influenced by country hospital doctors. Fourth, we only collected prescriptions in hospitals but not actual antibiotics taken at home, where antibiotics could be easily available in street pharmacies. Future study should consider actual volume of antibiotics patient consumed to better guide AMS policies.
Despite the limitations, our study clearly demonstrates that the reduction in antibiotic use may be associated with policies implemented in the intervention hospital. Previous studies were conducted in primary care facilities and focused on costs. They demonstrated that the national essential medicines scheme and zero-mark-up policy have effectively reduced the purchasing prices of medicines on the list [7] , and the average cost per prescription [8, 24] . One study reported reduction in prescribing antibiotics due to their limited availability, [8] but others did not observe any change on APRs [24] . Another study reported that APRs declined overtime in the province of Inner Mongolia [25] . However, these studies did not have a parallel comparison and used APR of all outpatient prescriptions, not considering the clinical case-mix.
We did not observe any significant change regarding inappropriate use of antibiotics for inpatients. This may due to the relatively small number of inpatient records we obtained with a primary diagnosis of URTIs. However, promoting appropriate use of antibiotics for inpatients may require substantial clinical training, which was not observed in either group. We also identified extensive use of broad-spectrum antibiotics in treating URTIs, which echoed similar findings in Vietnam [26] . This may reflect a lack of specific diagnosis of the location of infection and a lack of knowledge that broad-spectrum antibiotics should not be used for URTIs [17, 19] .
Our qualitative study revealed that the national essential medicines scheme and zero-mark-up policy have been powerful tools to cut the linkage between prescribing and hospital revenues, which was essential but not sufficient to reduce antibiotic prescribing. Our interviews revealed that use of guidelines may have improved doctors' knowledge, but it was the prescription review which the doctors cared most. It indicated that the zero-mark-up policy has to be coupled with the AMS policy for any apparent effect in reducing APR. Based on our observations, the national essential medicines scheme and zeromark-up policy limited antibiotics availabilities and delinked hospital revenue from prescribing. This may be reflected in the fact that far less cephalosporin III, an expensive antibiotic, was prescribed in the intervention than in the comparison group. Doctors' prescribing behaviour is a complex issue that is influenced by both intrinsic (such as knowledge) and extrinsic factors (such as patient symptoms, use of guidelines and peer practice) [27] . The intervention hospital translated the policies into a local AMS programme through training for doctors on guidelines, prescription review and restricting non-compliant doctors -which may be associated with reduced APR for outpatients. We knew that limited administrative measures, such as posting individual doctor's APRs publicly, were ineffective [28] . This has to be a combined effort. A recent trial in the USA showed that use of guidelines, recording justifications for antibiotic use and peer review was effective in reducing inappropriate antibiotic use [29] . We further added interventions at the patient side in a prospective trial as targeting both doctors and patients has shown a larger effect than targeting only one of them [30, 12] .
In conclusion, we found that the national essential medicines scheme and zero-mark-up policy, when implemented with AMS strategies, may be associated with reductions in antibiotic prescribing and use of intravenous infusions in county hospitals. Implementation of these policies, through training, peer review of prescriptions and penalties for overprescribing doctors, is crucial for success.
